You are here

SPK-8011

Roche targets 2021 start for hemophilia A gene therapy phase 3 as optimization effort drags on

Fierce Biotech

Mon, 07/13/20 - 11:11 am

Spark Therapeutics

What's Next for Spark Therapeutics

Motley Fool

Wed, 08/15/18 - 09:50 am

Spark Therapeutics

3 Biotech Stocks With Major Catalysts Incoming

Motley Fool

Tue, 07/3/18 - 11:04 am

Spark Therapeutics

Progenics Pharmaceuticals

ASH17: Spark gene therapy falls behind BioMarin in hemophilia

BioPharma Dive

Tue, 12/12/17 - 10:50 pm

Spark Therapeutics

9 Notable Biotechs Presenting At This Year's ASH Meeting

Yahoo

Tue, 11/7/17 - 09:56 am

Ziopharm Oncology

Spark Therapeutics

Juno Therapeutics

Spark offers a glimpse of efficacy in first two hemophilia A gene therapy patients

Endpoints

Wed, 08/2/17 - 09:39 am

Spark Therapeutics